Rephonic
Artwork for PeerVoice Oncology & Haematology Audio

PeerVoice Oncology & Haematology Audio

PeerVoice
Non-Small Cell Lung Cancer
MET Alterations
Metastatic Colorectal Cancer
Paroxysmal Nocturnal Hemoglobinuria
Therapeutic Techniques
Clinical Trials
Urothelial Carcinoma
Prostate Cancer
DNA NGS
RNA NGS
Biomarker Testing
Precision Medicine
Radioligand Therapy
Multidisciplinary Management
Chemoradiotherapy
RAS Mutations
Immunotherapy
Targeted Therapy
Trop2-Directed Therapy
Hormone Receptor-Positive Breast Cancer

PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Oncology & Haematology that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: peervoice.com.

PublishesWeeklyEpisodes157Founded15 years ago
Number of ListenersCategories
Health & FitnessMedicineScience

Listen to this Podcast

Artwork for PeerVoice Oncology & Haematology Audio

Latest Episodes

For the complete activity, including supporting material, please visit www.peervoice.com/RKZ860. Presented by Pier Luigi Zinzani, MD, PhD. Learning Objectives: Recall signs, symptoms, and outcomes associated with idiopathic multicentric Castl... more

For the complete activity, including supporting material, please visit www.peervoice.com/FAN860. Presented by Austin Kulasekararaj, MD, MRCP, FRCPath; and Bruno Fattizzo, MD Learning Objectives: Discuss the criticality of achieving and sustai... more

For the complete activity, including supporting material, please visit www.peervoice.com/KBA860. Presented by Jonathan W. Goldman, MD and Misty Dawn Shields, MD, PhD. Learning Objectives: Recall the current evidence base and guideline recomme... more

For the complete activity, including supporting material, please visit www.peervoice.com/AHU860. Presented by Matthew J. Koster, MD and Carmelo Gurnari, MD, PhD. Learning Objectives: Identify and distinguish the clinical presentation of VEXAS... more

For the complete activity, including supporting material, please visit www.peervoice.com/GNV860. Presented by Cristina Saura Manich, MD, PhD and Aditya Bardia, MD. Learning Objectives: Evaluate the clinical data for emerging therapeutic strat... more

Visit www.peervoice.com/FRH860 to view the entire programme with slides. After completing “Régis Peffault de Latour, MD, PhD - Stepping Out of the Grey: Beyond Anaemia and Towards Visibility for Patients With PNH”, participants will be able t... more

Visit www.peervoice.com/CCM860 to view the entire programme with slides. After completing “Rebecca Dent, MD, FRCP (Canada) - TROP2 and Triple-Negative Breast Cancer: The Rationale and Emerging Evidence for Exploring the Therapeutic Potential ... more

Visit www.peervoice.com/FCE860 to view the entire programme with slides. After completing “Francesco Passamonti, MD - Myelofibrosis Under the Microscope: Exploring p53 Dysregulation as a Potential Therapeutic Target”, participants will be abl... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Juning Li
Associate Professor and Medical Oncologist
MD Anderson
Episode: Jonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
Diana Ionescu
Head of the Anatomical Pathology Department
University of British Columbia
Episode: Jonathan W. Goldman, MD - Don’t Forget About MET: Keys to Detecting and Targeting MET Alterations as a Therapeutic Vulnerability in NSCLC
Louise Haemat
Nuclear physician at St. Vincent Hospital
St. Vincent Hospital
Episode: Bertrand Tombal, MD, PhD - MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optimise Outcomes
Anmohan Chong
Urologist at National University Hospital
National University Hospital
Episode: Bertrand Tombal, MD, PhD - MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optimise Outcomes

Top Science Podcasts

Something You Should Know
Something You Should KnowMike Carruthers | OmniCast Media
Hidden Brain
Hidden BrainHidden Brain, Shankar Vedantam
Radiolab
RadiolabWNYC Studios
StarTalk Radio
StarTalk RadioNeil deGrasse Tyson
Big Ideas Lab
Big Ideas LabMission.org
Science Friday
Science FridayScience Friday and WNYC Studios
Blurry Creatures
Blurry CreaturesBlurry Creatures

Talking Points

Recent interactions between the hosts and their guests.

Bertrand Tombal, MD, PhD - MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optimise Outcomes
Q: What are the specificities of radioligand therapy administration?
Patients get intravenous administration and remain radioactive for a few hours until most of it is excreted through urine; management of side effects is also crucial.
Bertrand Tombal, MD, PhD - MDT Management of Patients Receiving Radioligand Therapy: Strategies to Optimise Outcomes
Q: What is the rationale for ligand therapy?
The rationale is about targeted treatment, which involves delivering high doses of radiation directly to the cell using small proteins with nuclear warheads.
Sara Hurvitz, MD - A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Advanced Breast Cancer
Q: Where should we be utilizing TROP2-directed ADCs in which patients?
The TROP2-directed ADCs should be utilized in the setting of patients who have received endocrine treatment and at least two lines of systemic therapy.
Sara Hurvitz, MD - A New Jigsaw Piece for Our Patient’s Puzzle: TROP2-Directed Therapy in HR+ Advanced Breast Cancer
Q: Can you talk to us about these novel antibody drug conjugates and how they work?
Novel antibody drug conjugates differ from classic chemotherapy by selectively delivering chemotherapy through antibody targeting, thus enhancing efficacy and reducing off-target toxicity.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About PeerVoice Oncology & Haematology Audio

What is PeerVoice Oncology & Haematology Audio about and what kind of topics does it cover?

The content prominently features discussions on the latest advancements and treatment protocols in oncology and hematology, providing insights from leading medical experts in the field. Episodes cover a range of topics such as novel therapies, management strategies for specific cancers, and emerging trends in personalized medicine. There is a particular emphasis on practical applications of novel research findings and clinical trials, delivering valuable knowledge targeted at healthcare professionals interested in improving patient outcomes. This educational approach, aimed at practitioners, is a distinctive aspect that sets the content apart, making it a useful resource for medical experts seeking to stay abreast of developments in cancer ... more

Where can I find podcast stats for PeerVoice Oncology & Haematology Audio?

Rephonic provides a wide range of podcast stats for PeerVoice Oncology & Haematology Audio. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to PeerVoice Oncology & Haematology Audio and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does PeerVoice Oncology & Haematology Audio get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for PeerVoice Oncology & Haematology Audio, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for PeerVoice Oncology & Haematology Audio?

Rephonic provides comprehensive predictive audience data for PeerVoice Oncology & Haematology Audio, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does PeerVoice Oncology & Haematology Audio have?

To see how many followers or subscribers PeerVoice Oncology & Haematology Audio has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to PeerVoice Oncology & Haematology Audio?

These podcasts share a similar audience with PeerVoice Oncology & Haematology Audio:

1. Breast Cancer Update

How many episodes of PeerVoice Oncology & Haematology Audio are there?

PeerVoice Oncology & Haematology Audio launched 15 years ago and published 157 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact PeerVoice Oncology & Haematology Audio?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for PeerVoice Oncology & Haematology Audio?

Rephonic pulls ratings and reviews for PeerVoice Oncology & Haematology Audio from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for PeerVoice Oncology & Haematology Audio?

Rephonic provides full transcripts for episodes of PeerVoice Oncology & Haematology Audio. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on PeerVoice Oncology & Haematology Audio?

Recent guests on PeerVoice Oncology & Haematology Audio include:

1. Juning Li
2. Diana Ionescu
3. Louise Haemat
4. Anmohan Chong

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days